Clinical Trial Update: Interferon and GM-CSF Compared With Imatinib Mesylate and Vaccine Therapy in Patients With Chronic Phase CML on a TKI [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial comparing interferon and GM-CSF with imatinib mesylate and vaccine therapy in chronic phase CML patients on a TKI has completed with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• GM-CSF (granulocyte-macrophage colony-stimulating factor)
• Imatinib mesylate (Imatinib)
• Interferon (interferon)
• Vaccine therapy

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2018-11-13